I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Corrigendum: A highly potent anti-VISTA antibody KVA12123 -..:
Shawn Iadonato
;
Yulia Ovechkina
;
Kurt Lustig
...
https://www.frontiersin.org/articles/10.3389/fimmu.2024.1365240/full. , 2024
Link:
https://doi.org/10.3389/fimmu.2024.1365240
RT Journal T1 <Title>Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d1fca6d15d194deca444175932122942&Exemplar=1&LAN=DE A1 Shawn Iadonato A1 Yulia Ovechkina A1 Kurt Lustig A1 Jessica Cross A1 Nathan Eyde A1 Emily Frazier A1 Neda Kabi A1 Chen Katz A1 Remington Lance A1 David Peckham A1 Shaarwari Sridhar A1 Carla Talbaux A1 Isabelle Tihista A1 Mei Xu A1 Thierry Guillaudeux PB Frontiers Media S.A. YR 2024 K1 Vista K1 PD-1H K1 B7-H5 K1 immune checkpoint inhibitor K1 immunotherapy K1 PD-1 combination therapy K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2024.1365240/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2024.1365240 DO https://doi.org/10.3389/fimmu.2024.1365240 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
